Literature DB >> 8237472

Post-translational control of collagen fibrillogenesis in mineralizing cultures of chick osteoblasts.

L C Gerstenfeld1, A Riva, K Hodgens, D R Eyre, W J Landis.   

Abstract

Cultured osteoblasts from chick embryo calvaria were used as a model system to investigate the post-translational extracellular mechanisms controlling the macroassembly of collagen fibrils. The results of these studies demonstrated that cultured osteoblasts secreted a collagenous extracellular matrix that assembled and mineralized in a defined temporal and spatial sequence. The assembly of collagen occurred in a polarized fashion, such that successive orthogonal arrays of fibrils formed between successive cell layers proceeding from the culture surface toward the media. Mineralization followed in the same manner, being observed first in the deepest and oldest fibril layers. Collagen fibrillogenesis, the kinetics of cross-link formation, and collagen stability in the extracellular matrix of the cultures were examined over a 30 day culture period. Between days 8 and 12 in culture, collagen fibril diameters increased from < 30 nm to an average of 30-45 nm. Thereafter, diameters ranged in size from 20 to 200 nm. Quantitation of the collagen cross-linking residues, hydroxylysyl pyridinoline (HP) and lysyl pyridinoline (LP), showed that these mature cross-links increased from undetectable levels to concentrations found in normal chick bone. Analysis of the kinetics of their formation by pulse-chase labeling the cultures with [3H]lysine showed a doubling time of approximately 5 days. The relationships between cross-link formation, fibrillogenesis, and collagen stability were examined in cultures treated with beta-aminopropionitrile (beta-APN), a potent inhibitor of lysyl oxidase and cross-link formation. In beta-APN-treated cultures, total collagen synthesis was increased twofold, with no change in mRNA levels for type I collagen, whereas the amount of collagen accumulated in the cell layer was decreased by 50% and mineral deposition was reduced. The rate of collagen retention in the matrix was assessed by pulse-chase analysis of [3H]proline over a 16 day period in control and beta-APN-treated cultures. In control cultures, about 20% of the labeled collagen was lost from the cell layers over a 16 day period compared with > 80% in the presence of beta-APN. The beta-APN-treated cultures also showed a wider diversity of fibril diameters with a median in the > 45-60 nm range. In summary, these data suggest that cross-linking and assembly of collagen fibrils secreted by osteoblasts in vitro occur in a fashion similar to that found in vivo. The rate of cross-link formation is relatively constant and may be correlated with increasing collagen mass.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Keywords:  NASA Discipline Musculoskeletal; NASA Discipline Number 40-40; NASA Program Space Biology; Non-NASA Center

Mesh:

Substances:

Year:  1993        PMID: 8237472     DOI: 10.1002/jbmr.5650080903

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  16 in total

1.  Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation.

Authors:  Zhaoyong Li; Mohammad Q Hassan; Mohammed Jafferji; Rami I Aqeilan; Ramiro Garzon; Carlo M Croce; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  J Biol Chem       Date:  2009-04-02       Impact factor: 5.157

2.  Variation in type I collagen fibril nanomorphology: the significance and origin.

Authors:  Ming Fang; Mark M Banaszak Holl
Journal:  Bonekey Rep       Date:  2013-08-21

3.  HIF-1α metabolically controls collagen synthesis and modification in chondrocytes.

Authors:  Steve Stegen; Kjell Laperre; Guy Eelen; Gianmarco Rinaldi; Peter Fraisl; Sophie Torrekens; Riet Van Looveren; Shauni Loopmans; Geert Bultynck; Stefan Vinckier; Filip Meersman; Patrick H Maxwell; Jyoti Rai; MaryAnn Weis; David R Eyre; Bart Ghesquière; Sarah-Maria Fendt; Peter Carmeliet; Geert Carmeliet
Journal:  Nature       Date:  2019-01-16       Impact factor: 49.962

Review 4.  Charting the unexplored extracellular matrix in cancer.

Authors:  Elysse C Filipe; Jessica L Chitty; Thomas R Cox
Journal:  Int J Exp Pathol       Date:  2018-04-19       Impact factor: 1.925

5.  Decorin modulates collagen matrix assembly and mineralization.

Authors:  Yoshiyuki Mochida; Duenpim Parisuthiman; Suchaya Pornprasertsuk-Damrongsri; Phimon Atsawasuwan; Marnisa Sricholpech; Adele L Boskey; Mitsuo Yamauchi
Journal:  Matrix Biol       Date:  2008-11-18       Impact factor: 11.583

6.  Exercise increases pyridinoline cross-linking and counters the mechanical effects of concurrent lathyrogenic treatment.

Authors:  Erin M B McNerny; Joseph D Gardinier; David H Kohn
Journal:  Bone       Date:  2015-07-23       Impact factor: 4.398

7.  Maintenance of a bone collagen phenotype by osteoblast-like cells in 3D periodic porous titanium (Ti-6Al-4 V) structures fabricated by selective electron beam melting.

Authors:  Nikolas W Hrabe; Peter Heinl; Rajendra K Bordia; Carolin Körner; Russell J Fernandes
Journal:  Connect Tissue Res       Date:  2013-09-30       Impact factor: 3.417

8.  Bone fracture toughness and strength correlate with collagen cross-link maturity in a dose-controlled lathyrism mouse model.

Authors:  Erin M B McNerny; Bo Gong; Michael D Morris; David H Kohn
Journal:  J Bone Miner Res       Date:  2015-03       Impact factor: 6.741

9.  Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity.

Authors:  Phimon Atsawasuwan; Yoshiyuki Mochida; Michitsuna Katafuchi; Masaru Kaku; Keith S K Fong; Katalin Csiszar; Mitsuo Yamauchi
Journal:  J Biol Chem       Date:  2008-10-02       Impact factor: 5.157

10.  Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.

Authors:  Siddharth R Vora; Amitha H Palamakumbura; Maria Mitsi; Ying Guo; Nicole Pischon; Matthew A Nugent; Philip C Trackman
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.